DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Mike Grey will speak on "What Are the Funding Sources and How to Apply" at the American Chemical Society meeting in San Diego, CA
News | 10. 09. 2010
